TC Biopharm (Holdings) Management
Management criteria checks 3/4
TC Biopharm (Holdings)'s CEO is Bryan Kobel, appointed in Jun 2021, has a tenure of 3.42 years. total yearly compensation is £427.17K, comprised of 83.3% salary and 16.7% bonuses, including company stock and options. directly owns 0.44% of the company’s shares, worth $1.51K. The average tenure of the management team and the board of directors is 3.1 years and 2.5 years respectively.
Key information
Bryan Kobel
Chief executive officer
UK£427.2k
Total compensation
| CEO salary percentage | 83.3% |
| CEO tenure | 3.4yrs |
| CEO ownership | 0.4% |
| Management average tenure | 3.1yrs |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -UK£9m |
| Dec 31 2023 | UK£427k | UK£356k | -UK£6m |
| Sep 30 2023 | n/a | n/a | -UK£4m |
| Jun 30 2023 | n/a | n/a | -UK£2m |
| Mar 31 2023 | n/a | n/a | -UK£2m |
| Dec 31 2022 | UK£436k | UK£363k | -UK£1m |
Compensation vs Market: Bryan's total compensation ($USD538.04K) is about average for companies of similar size in the US market ($USD653.78K).
Compensation vs Earnings: Bryan's compensation has been consistent with company performance over the past year.
CEO
Bryan Kobel (45 yo)
3.4yrs
Tenure
UK£427,169
Compensation
Mr. Bryan Leland Kobel serves as Chief Executive Officer at TC Biopharm Limited. Mr. Kobel serves as Chief Executive Officer of TC Biopharm (Holdings) Plc since June 2021 and serves as Director. He joined...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.4yrs | UK£427.17k | 0.44% $ 1.5k | |
| CFO & Director | 5.7yrs | UK£322.02k | 0.00018% $ 0.6 | |
| Executive Vice President of Communications | 2.8yrs | no data | no data | |
| Head of Commercial Development Division | less than a year | no data | no data |
3.1yrs
Average Tenure
Experienced Management: TCBP's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | no data | UK£427.17k | 0.44% $ 1.5k | |
| CFO & Director | 8.7yrs | UK£322.02k | 0.00018% $ 0.6 | |
| Non-Executive Independent Chair | 2.8yrs | UK£23.53k | 0% $ 0 | |
| Chairman of Scientific Advisory Board | 2.5yrs | UK£23.53k | 0% $ 0 | |
| Non-Executive Independent Director | 2.8yrs | UK£23.53k | 0% $ 0 | |
| Member of Scientific Advisory Board | 2.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.1yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.1yrs | no data | no data |
2.5yrs
Average Tenure
70yo
Average Age
Experienced Board: TCBP's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.